Law360 Highlights Robbins Geller Class Certification Victory for Johnson & Johnson Investors

The Honorable Zahid N. Quraishi certified a class of Johnson & Johnson investors on Friday, December 29, and named Robbins Geller Rudman & Dowd LLP as class counsel.

The class action alleges Johnson & Johnson created an artificially inflated stock price by failing to disclose known cancer risks associated with its popular Baby Powder and other talc-based products, actively concealing damning internal documents and information and conducting a years-long scheme to influence and manipulate regulators and scientists. According to the article, Johnson & Johnson’s stock prices allegedly cratered when news outlets published articles exposing the company’s knowledge of the presence of asbestos.

The case is pending in the United States District Court for the District of New Jersey. 

Read the Law360 article at https://www.law360.com/articles/1780950/j-j-investors-score-class-cert-in-talc-concealment-suit

About Robbins Geller

Robbins Geller Rudman & Dowd LLP is one of the world’s leading complex litigation firms, representing plaintiffs in securities fraud, shareholder derivative, antitrust, corporate takeover, and consumer fraud and privacy cases. With 200 lawyers in 10 offices, Robbins Geller is one of the world’s largest plaintiffs’ firms, and the Firm’s attorneys have obtained many of the largest securities, antitrust, and consumer class action recoveries in history.

The Firm is ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report for recovering more than $1.75 billion for investors in 2022 — the third year in a row Robbins Geller tops the list. And in those three years alone, Robbins Geller recovered nearly $5.3 billion for investors, more than double the amount recovered by any other plaintiffs’ firm. The Firm secured the largest-ever securities fraud class action settlement — $7.2 billion — in In re Enron Corp. Securities Litigation.

For media inquiries, please contact media@rgrdlaw.com or call (619) 338-3821.

Hall v. Johnson & Johnson, No. 3:18-cv-01833 (D.N.J.).